Swain, Risa Mia
Contreras, Lisett
Varela-Ramirez, Armando
Hossain, Mohammad
Das, Umashankar
Valenzuela, Carlos A.
Penichet, Manuel L.
Dimmock, Jonathan R.
Aguilera, Renato J
Funding for this research was provided by:
NIGMS (R25GM069621-18, R25GM069621-18)
National Institute on Minority Health and Health Disparities (5U54MD007592, 5U54MD007592)
Maunders McNeil Foundation Inc., Canada
Article History
Received: 30 March 2022
Accepted: 1 June 2022
First Online: 6 July 2022
Declarations
:
: Dr. Manuel L. Penichet has a financial interest in Stellar Biosciences, Inc. The regents of the University of California are in discussions with Stellar Biosciences to license a technology invented by Dr. Penichet to this firm. In addition, Dr. Penichet has a financial interest in Klyss Biotech, Inc. All the other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The other authors declare that they have no conflict of interest.
: This article does not contain any studies on human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.
: The authors have declared that no competing interests exist.